Renita White, MD, is an obstetrician/gynecologist at Georgia Obstetrics and Gynecology in Atlanta, Georgia. Her areas of expertise include fibroids, irregular vaginal ...

Results show that targeting the underlying cause of Dravet syndrome with zorevunersen may improve outcomes for people with ...

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, ...

Quell Therapeutics is the world leader in developing engineered T-regulatory (Treg) cell therapies that aims to harness, direct and optimize their immune suppressive properties to address serious ...

NeuroPace, Inc. ( NPCE) Q4 2025 Earnings Call March 3, 2026 4:30 PM EST Good afternoon, and welcome to NeuroPace Fourth Quarter 2025 Conference Call. As a reminder, this call is being recorded.

Quell Therapeutics Ltd (“Quell”), a leader in developing engineered T-regulatory (Treg) cell therapies for serious ...

Held Type A meeting with FDA to discuss AMT-130 for Huntington’s disease; Company evaluating Phase III development considerations and plans to ...

Takeda (TSE:4502/NYSE:TAK) and Protagonist Therapeutics, Inc. ("Protagonist") today announced that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) and granted ...